Oncology Nutrition Market | Ongoing Trends and Recent Developments | Major Key Players like Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France)

Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the Oncology Nutrition Market. Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients|

What the Market Looks Like?

Predicted to grow at a CAGR of 8.7% during the forecast period, the Oncology Nutrition Market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023.

Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancer’s cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

Objectives of the Study:

• To define, describe, segment, and forecast the Oncology Nutrition Market for different types of cancer

• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and industry-specific opportunities)

• To forecast the size of the Oncology Nutrition Market, in four main regions —North America (along with countries), Europe (along with countries), Asia Pacific, and the Rest of the World
• To identify and profile key players in the global Oncology Nutrition Market and comprehensively analyze their core competencies and market shares

Get 10% Customization on Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=166703967

Geographical growth scenario of Oncology Nutrition Market:

The Oncology Nutrition Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.

Leading market players and strategies adopted:

The major players in the Oncology Nutrition Market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/oncology-nutrition.asp

Non Invasive Prenatal Testing Market by Product, Services, Method, Application & End-User

According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Browse and in-depth TOC on “Non Invasive Prenatal Testing Market”

110 - Tables

48 - Figures

150 - Pages

Download PDF Brochure - @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

To Get 10% Customization on Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690

On the basis of product, the market is classified into consumables and instruments. The consumable segment is further divided into assay kits & reagents and disposables. The instruments segment is divided into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst@https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=145607690

The market is highly fragmented with several big and emerging players. Key market players include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

Synthetic Biology Market by Application

 In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.

Browse and in-depth TOC on “Synthetic Biology Market”
162 - Tables
32 - Figures
214 - Pages

Get Bundle Reports @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889

By application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) applications. The biofuel and renewable energy segment is estimated to grow at the highest CAGR during the forecast period. This high growth rate is attributed to the rising popularity of biofuels and the advantages of using genetically engineered organisms for the synthetic production of biofuels.

Key players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). These players are increasingly collaborating, and partnering with companies to offer their synthetic oligonucleotides and to develop synthetic organisms.

Primary Cells Market worth $1,107.3 million by 2023

According to research report the report Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023", The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%.

Factors driving the growth of this market include increasing cancer research, high prevalence of cancer disorders, increasing research funding for the development of new cancer therapies, and increasing number of collaborations & acquisitions.

Hematopoietic cells segment is estimated to account for the largest share of the primary cells market in 2018.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=32854960



Based on origin, the market is segment into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells. The hematopoietic cells segment is witnessing a significant demand due to increasing cancer research globally. For instance, in 2014, cancer research represented more than 4% of overall research performed worldwide.

Human primary cells segment is anticipated to account for the largest share of the primary cells market in 2018.
The two major categories of primary cells by type included animal primary cells and human primary cells. Human primary cells are primarily used for various research applications, for instance, studying cancer stem cells and drug-drug interactions in cancerous cells and circulating tumor cells. The rising application areas of human stem cells and rising incidence of cancer are the key factors driving the growth of this market segment.
The life science research companies segment is estimated to grow at the highest CAGR during the forecast period.

The end user segment is further segmented into life science research companies and research institutes. The life science research companies segment is estimated to register the highest CAGR during the forecast period. The key factors that drive the growth of this segment is the rising application of primary cells in drug discovery and cancer research in life science research companies.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

North America is expected to command the largest share of the market during the forecast period.

Based on region, the global primary cells market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is estimated to dominate the primary cells market in 2017. This is mainly due to factors such as the increasing research on increasing prevalence of cancer related disorders, and presence of all key players in the region.
Key players in the primary cells market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

Visit: https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html

Global Gas Chromatography Market | Growth, Trends, and Forecast (2017-2022)

The overall gas chromatography market is expected to reach USD 3671.0 million by 2022 from USD 2647.0 million in 2016, at a CAGR of 6.2%.
The increasing crude & shale oil production, increasing importance of waste water treatment, rise in adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns and increased importance of chromatography tests in drug are the key factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10165677

Gas chromatography market segmentation:

• basis of instruments
• basis of accessories and consumables
• basis of end users
• basis of regions

The Major Players Operating in the Gas chromatography market

The gas chromatography market is dominated by Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), and PerkinElmer, Inc. (U.S.).

The prominent players in the Gas chromatography market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S.), Danaher Corporation (U.S.), Scion Instruments (Techcomp USA Inc.), LECO Corporation (U.S.), Merck KGaA (Germany), Falcon Analytical Systems & Technology, LLC (U.S.), Restek Corporation (U.S.), Dani Instruments S.p.A. (Italy), and Chromatotec (France).

Geographical Detailed Analysis for Gas chromatography market:

The geographic segments in this report include North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest sh gas chromatography market are of the market in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growth in food testing industries are driving the growth of the North American gas chromatography market.

Read More in Detailed (Gas chromatography market): https://www.marketsandmarkets.com/PressReleases/gas-chromatography.as

Cell Therapy Technologies Market by Product, Cell Type, Process Stages, End User, and Region

According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023", published by MarketsandMarkets™, The Cell Therapy Technologies Market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4%. Factors such as rising governent investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.

To Get Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, andrazil are emerging markets for cell therapy instruments.
These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.Browse and in-depth TOC on “Cell Therapy Technologies Market”
75 - Tables
30 - Figures
116 - Pages
Key Market Players
Key players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).
Thermo Fisher was the largest player in the cell therapy technologies market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=213334978

Bioinformatics Market : key players in the market and comprehensively analyse their market positions

The bioinformatics platforms segment is projected to grow at the highest rate during the forecast period. This high growth is attributed to an increase in the use of bioinformatics platforms in drug discovery and development.

Segments :

The bioinformatics market has been classified based on product & service, applications, sectors, and region. Based on product and service, the market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services.

The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and Protein Sequencing and the rising applications of bioinformatics in drug discovery, clinical diagnostics, and personalized medicine are key factors supporting the growth of this market. On the other hand, a lack of well-defined standards and common formats for Data Integration may limit market growth to a certain extent.

Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

On the basis of sector, the global market is divided into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, and forensic biotechnology. In 2018, the medical biotechnology segment is expected to account for the largest share of the global market. The rising adoption of bioinformatics tools in pharma and clinical applications is driving market growth.

Applications :

On the basis of applications, the global market is divided into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. In 2018, the genomics segment is expected to account for the largest share of the global market due to the increasing applications of genomics in personalized and preventive medicine.

Request for Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=39

Geographical Region :

In 2018, North America is expected to account for the largest share of the market. The large share of North America is attributed to the continued funding from the government and private sectors for life sciences research.

Leading Companies :

Prominent players in the bioinformatics market include SEC Filings, press releases, investor presentations, Oxford Journals, National Human Genome Research Institute (NHGRI), EMBL-European Bioinformatics Institute (EMBL-EBI), National Center for Biotechnology Information (NCBI), Genome Canada.

Varicose Vein Treatment Market: Competitive Landscape by Treatment Mode

According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.

Get 10% Free Customization on this report @
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22524107



The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis.

This report broadly segments the varicose vein treatment market into mode of treatment and products. The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

Browse and in-depth TOC on “Varicose Vein Treatment Market”
67 - Tables

19 - Figures

149 - Pages

Request Bundle Reports @
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=22524107

Objectives of the study are:

• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions
• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile the key players and comprehensively analyze their market shares

For Press release, visit:
https://www.marketsandmarkets.com/PressReleases/varicose-vein-treatment.asp

Western Blotting Market - Growth Strategy Adopted By Top Players

According to the new market research report “Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021", published by MarketsandMarkets™, This report studies the global western blotting market for the forecast period of 2016 to 2021. This market is expected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9 %. The global western blotting market is segmented on the basis of product, application, end user and region.

Get 10% Free Customization on this Reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=235810711
In the coming years, the western blotting market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.


North America is expected to account for the largest share of the global market. This can be attributed to the increasing prevalence of HIV and Lyme disease in the U.S., rise in research funding and increasing production of genetically modified crops in the U.S., U.S.-China collaborative program for biomedical research, and HIV vaccine initiative in Canada.

The global western blotting market, based on the application is segmented into biomedical & biochemical research, disease diagnostics, agriculture, disease diagnostics, biologics, and quality control, among others. The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021.

Browse and in-depth TOC on “Western Blotting Market”
132 - Tables

41 - Figures

169 - Pages

Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the market worldwide.

To know more speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711

Genotyping Assay Market worth $31.9 billion by 2023

According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.

Get 10% Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=249958595



The growth of this market is mainly driven by technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.

The genotyping market in the APAC is expected to grow at the highest CAGR during the forecast period. This is due to the increasing incidence of chronic diseases, and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases and the spread of infectious and microbial diseases in APAC countries. Global pharmaceutical and biopharmaceutical companies are also increasingly outsourcing clinical research and trials to companies in this region, which has increased the demand for genotyping products for drug profile assessment, drug efficacy and safety assessment, dosing determination, and drug response evaluation.

The reagents & kits segment is expected to grow at the highest CAGR during the forecast period
Based on product, the reagents and kits are expected to grow at the highest rate during the forecast period. This segment is expected to witness the highest CAGR due to the easy accessibility of a wide range of reagents and the increasing need for genotyping in various applications.

Browse and in-depth TOC on “Genotyping Market”
219 - Tables

53 - Figures

280 - Pages

Request Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=249958595

The prominent players in the global genotyping market are Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Digital Therapeutics Market worth 457.9 Million USD by 2021

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

On the basis of application, the digital therapeutics market is segmented into preventive and treatment/care-based applications. On the basis of sales channel, the digital therapeutics market is segmented into B2C and B2B sales channel. The B2B segment is estimated to command the largest share in 2016 and register the highest CAGR in the digital therapeutics market, by sales channel. Factors such as growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug products are driving the growth of this segment.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724



Based on geography, the global digital therapeutics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2016. This large share can be attributed to various factors, including growing incidence of chronic diseases, government initiatives to support technological advancements in the field of digital therapeutics, and a growing influx of new startup companies in the market.

Prominent players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724

HLA Typing for Transplant Market Research Report 2021

According to the new market research report " HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021", published by MarketsandMarkets™,The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021.

Don’t miss out on business opportunities in HLA Typing for Transplant Market, visit: https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742

Browse and in-depth TOC on " HLA Typing for Transplant Market " 

60 - Figures 
203 - Pages 


Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742 

This report studies the global HLA typing for transplant market over the forecast period of 2016 to 2021.

Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantation; increased funding, research grants, and public-private investments; technological shift from serological assays to gene-based HLA profiling; and improving healthcare infrastructure across developing countries.

To know about the assumptions considered for the study, download the pdf brochure@https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742

Growth in the sequencing-based molecular assay segment is mainly driven by the growing market demand for high-throughput DNA sequencers in HLA typing, rising end-user preference for low-cost and efficient DNA sequencing technologies, expansion in application horizons of NGS in tissue typing, and increasing usage of NGS systems among researchers and diagnostic laboratories. The PCR-based molecular assay segment is expected to hold a larger share of the global HLA typing for transplant market for molecular assay technology in 2016.

The global Walking Assist Devices Market report defines and segments the walking assist devices market globally with analysis and forecast of revenue. The global walking assist devices market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

The global walking assist devices market growth is attributed to the rising aging population, increasing incidences of debilitating neurological diseases & injuries, and technological advancements & product leasing that have led to the increase in usage of walking assist devices.

The rise in elderly population and increasing technological advancements are some factors that have led to the growth of the global walking assist devices market. According to the World Health Organization (WHO), the global population in the age group of 60 years and above is expected to grow from 841 Million in 2013 to more than 2 Billion by 2050, which is more than double the population as of 2013.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24035174

This market is segmented and forecast on the basis of product, and geography. The product comprises of gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, Asia-pacific and Rest of the World (RoW). These major geographies are further sub-segmented into major countries. The global walking assist devices market was dominated by North America in 2014.

The market in North America is growing due to rise in aging population and favorable reimbursement. The European market is growing due to the technological advancements and government support and along with increase in the spending capacity population.

Receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=24035174

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide walking assist devices as a product.

The research study is aimed at identifying emerging trends and opportunities in the global walking assist devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global walking assist devices market, on the basis of product, and region.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=24035174

Walking Assist Devices Market worth 6.57 Billion USD by 2020

The global Walking Assist Devices Market report defines and segments the walking assist devices market globally with analysis and forecast of revenue. The global walking assist devices market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.The global walking assist devices market growth is attributed to the rising aging population, increasing incidences of debilitating neurological diseases & injuries, and technological advancements & product leasing that have led to the increase in usage of walking assist devices.The rise in elderly population and increasing technological advancements are some factors that have led to the growth of the global walking assist devices market. According to the World Health

Organization (WHO), the global population in the age group of 60 years and above is expected to grow from 841 Million in 2013 to more than 2 Billion by 2050, which is more than double the population as of 2013.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24035174 

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide walking assist devices as a product.

Browse and in-depth TOC on “Walking Assist Devices Market”

108 - Tables

112 - Figures

168 - Pages

The research study is aimed at identifying emerging trends and opportunities in the global walking assist devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global walking assist devices market, on the basis of product, and region.

Receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=24035174

The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, new product launch, M&A, and product approvals of the major companies would be detailed. Honda Motor Co., Ltd., Permobil Inc., GF Health Products, Inc., Invacare Corporation, Besco Medical Co., LTD., Betterlifehealthcare Ltd., C.T.M. Homecare Product, Inc., Ottobock, Ossenberg GmbH, Pride Mobility Products Corp., Aetna Inc., Sunrise Medical (US) LLC, and Karma Healthcare Ltd., are some of the key players operating in this market. These companies have adopted various strategies, such as merger & acquisition and partnership, among others, to achieve growth in the global market.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=24035174